These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 34599529)
1. Successful use of Impella 5.5 to manage cardiogenic shock complicated by COVID-19. Mahrokhian SH; Nordan T; Ortoleva JP; Cobey FC; Chen FY; Kapur NK; Kawabori M J Card Surg; 2021 Dec; 36(12):4783-4785. PubMed ID: 34599529 [TBL] [Abstract][Full Text] [Related]
2. Cardiogenic shock with highly complicated course after influenza A virus infection treated with vva-ECMO and Impella CP (ECMELLA): a case report. Ebert D; Mungard N; Mensch A; Homeister L; Willsch J; Ibe R; Baust H; Stiller M; Rebelo A; Ukkat J; Rigopoulos AG; Weber E; Bucher M; Noutsias M BMC Cardiovasc Disord; 2021 Nov; 21(1):528. PubMed ID: 34743690 [TBL] [Abstract][Full Text] [Related]
3. Mechanical circulatory support with the Impella® LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: The IMPELLA-STIC randomized study. Bochaton T; Huot L; Elbaz M; Delmas C; Aissaoui N; Farhat F; Mewton N; Bonnefoy E; Arch Cardiovasc Dis; 2020 Apr; 113(4):237-243. PubMed ID: 31740272 [TBL] [Abstract][Full Text] [Related]
4. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry. Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up. Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627 [TBL] [Abstract][Full Text] [Related]
6. Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review. Noone S; Flinspach AN; Fichtlscherer S; Zacharowski K; Sonntagbauer M; Raimann FJ BMC Anesthesiol; 2022 Dec; 22(1):385. PubMed ID: 36503438 [TBL] [Abstract][Full Text] [Related]
7. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047 [TBL] [Abstract][Full Text] [Related]
8. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock. Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321 [TBL] [Abstract][Full Text] [Related]
9. Microaxial devices for ventricular failure: a multicentre, population-based experience. Higgins J; Lamarche Y; Kaan A; Stevens LM; Cheung A Can J Cardiol; 2011; 27(6):725-30. PubMed ID: 21983112 [TBL] [Abstract][Full Text] [Related]
10. Impella CP use in patients with non-ischaemic cardiogenic shock. Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous Left Ventricular Assist Device Leads to Heart Rhythm Stabilisation in Cardiogenic Shock: Results from the Dresden Impella Registry. Mierke J; Loehn T; Ende G; Jahn S; Quick S; Speiser U; Jellinghaus S; Pfluecke C; Linke A; Ibrahim K Heart Lung Circ; 2021 Apr; 30(4):577-584. PubMed ID: 33039280 [TBL] [Abstract][Full Text] [Related]
12. Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre. Monteagudo Vela M; Simon A; Riesgo Gil F; Rosenberg A; Dalby M; Kabir T; García Saez D; Panoulas V Cardiovasc Revasc Med; 2020 May; 21(5):629-637. PubMed ID: 31859100 [TBL] [Abstract][Full Text] [Related]
14. Insertion technique for the Impella 5.0 heart pump in the COVID-19 era. Berman M; Nachum E; Osman M; Hogan J; Hoole S; Catarino P Multimed Man Cardiothorac Surg; 2020 Dec; 2020():. PubMed ID: 33399285 [TBL] [Abstract][Full Text] [Related]
15. Combined pulmonary and left ventricular support with veno-pulmonary ECMO and impella 5.0 for cardiogenic shock after coronary surgery. Sayed S; Schimmer C; Shade I; Leyh R; Aleksic I J Cardiothorac Surg; 2017 May; 12(1):38. PubMed ID: 28532425 [TBL] [Abstract][Full Text] [Related]
17. Mechanical circulatory support with the Impella 5.0 and the Impella Left Direct pumps for postcardiotomy cardiogenic shock at La Pitié-Salpêtrière Hospital. David CH; Quessard A; Mastroianni C; Hekimian G; Amour J; Leprince P; Lebreton G Eur J Cardiothorac Surg; 2020 Jan; 57(1):183-188. PubMed ID: 31270535 [TBL] [Abstract][Full Text] [Related]
18. Preliminary experience with Impella Recover(®) LP5.0 in nine patients with cardiogenic shock: a new circulatory support system in the intensive cardiac care unit. Bresson D; Sibellas F; Farhat F; Jegaden O; Kirkorian G; Bonnefoy E Arch Cardiovasc Dis; 2011 Aug; 104(8-9):458-64. PubMed ID: 21944148 [TBL] [Abstract][Full Text] [Related]
19. Successful Use of Surgically Placed Impella 5.0 and Central Extracorporeal Membrane Oxygenation Circuit in a Patient with Postcardiotomy Shock. Abu Saleh WK; Mason P; Jabbari OA; Samir H; Bruckner BA Tex Heart Inst J; 2015 Dec; 42(6):569-71. PubMed ID: 26664314 [TBL] [Abstract][Full Text] [Related]
20. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group. Doshi R; Patel K; Decter D; Jauhar R; Meraj P Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]